CNXUNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends October 31
Conexeu Sciences Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$3.29+0.23 (+7.52%)
Close on Oct 19, 2026
- Market cap
- $88.74M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
7 of Conexeu Sciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 20, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2026 | Sep 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2026 | Jul 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 15, 2026 | SEC EDGAR |